Lupin’s Mandideep Unit II Facility Receives EIR from US FDA EP News Bureau Apr 15, 2020 The inspection at the facility was carried out by the US FDA between November 26, 2018 and December 4, 2018
Lupin gets warning letter from US FDA for Mandideep facility Press Trust of India Sep 19, 2019 Lupin said there are no drug master file and abbreviated new drug applications (ANDA) pending review or approval from the…